Precision medicine offers a glimmer of hope for Alzheimer’s disease

"The decades long search for effective ways to treat or prevent Alzheimer’s disease is littered with failures, leaving 5.7 million Americans already stricken with this form of dementia without a lifeline. The rest of us are left to hope we won’t be among the 1 in 10 over 65 who gets the devastating diagnosis.

But precision medicine — an approach that is changing the treatment of cancer and spawning targeted therapies for a wide range of diseases — may open new avenues for the treatment of Alzheimer’s disease. And new ways to test experimental treatments promise to more quickly identify treatments that work, and perhaps the patients in whom they will work best.

Dementia specialists recently gathered at the Alzheimer’s Association’s International Conference in Chicago to assess the state of the field. And researchers gleaned some glimmers of real hope in both precision medicine and innovative trial designs to deliver new treatments for Alzheimer’s disease."

To read the full article, click HERE